Repatha and Ranitidine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repatha (evolocumab) and Ranitidine hydrochloride (ranitidine hydrochloride). Common drug interactions include anaemia among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Repatha and Ranitidine hydrochloride. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,256 Repatha users. Check the latest studies of Repatha.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

On Jul, 08, 2026

26 people who take Repatha and Ranitidine hydrochloride together, and have interactions are studied.

Repatha and Ranitidine hydrochloride drug interactions.

What are the common drug interactions of Repatha and Ranitidine Hydrochloride, by gender? *:

female:

Anaemia (lack of blood)
Anxiety
Chronic kidney disease
Depression
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Fear of disease
Gallbladder disorder
Iron deficiency
Irritable bowel syndrome
Mania (a state of abnormally elevated or irritable mood)

male:

Constipation
Malignant neoplasm progression (cancer tumour came back)
Drug ineffective
Drug intolerance (drug sensitivity)
Heart valve replacement
Muscle spasms (muscle contraction)
Pruritus (severe itching of the skin)
Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Anaphylactic reaction (serious allergic reaction)
Eye swelling

What are the common drug interactions of Repatha and Ranitidine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Constipation
Malignant neoplasm progression (cancer tumour came back)
Muscle spasms (muscle contraction)
Anaemia (lack of blood)
Anxiety
Chronic kidney disease
Depression
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Fear of disease
Gallbladder disorder

60+:

Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Influenza like illness
Anaphylactic reaction (serious allergic reaction)
Eye swelling
Lacrimation increased
Peripheral swelling
Alopecia (absence of hair from areas of the body)
Dementia (madness)
Drug intolerance (drug sensitivity)
Heart valve replacement

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 23.08%
High Blood Pressure: 5 people, 19.23%
Nausea (feeling of having an urge to vomit): 5 people, 19.23%
Weight Decreased: 4 people, 15.38%
Urinary Tract Infection: 4 people, 15.38%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 4 people, 15.38%
Blood Pressure Abnormal: 4 people, 15.38%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 4 people, 15.38%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 15.38%
Gastric Ulcer (stomach ulcer): 4 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and Ranitidine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously